Literature DB >> 30059639

A retrospective survey on herpes zoster disease burden and characteristics in Beijing, China.

Li Lu1, Luodan Suo1, Juan Li1, Xinghuo Pang1.   

Abstract

Little data are available on the overall incidence and characteristics of herpes zoster (HZ) in China, thus a community-based retrospective survey was conducted during December 2012 to March 2013 to collect HZ incident data over the past year in selected districts of Beijing, China. A total of 237 incident HZ cases were identified from 118,220 residents and majority of HZ patients (219/237, 92.4%) sought healthcare. Annual HZ incident rates were 1.90/1000 after adjusted and higher among females (2.4/1000) than males (1.7/1000). HZ rates increased with age and with a sharply rise among those aged ≥50 years particular for female. 217 cases were available for interview with 193 (88.9%) primary, 24 (11.1%) recurrent and 10 (4.6%) postherpetic neuralgia (PHN) cases respectively. No difference was shown between the primary and recurrent HZ cases in sex (P = 0.42), age (P = 0.72), times of healthcare seeking (P = 0.45), number of dermatome (P = 0.72), pain degree (P = 0.54), and hospitalization (P = 1.0). According to the survey, it can be speculated that disease burden of HZ is serious and caused at least 2.77 million cases annually in China. The recurrent HZ cases has similar characteristics to primary HZ cases. High proportion of healthcare seeking reminds that HIS records would be a feasible source for HZ surveillance to evaluate the trends and changes in China.

Entities:  

Keywords:  herpes zoster; incidence; postherpetic neuralgia; recurrent HZ

Mesh:

Year:  2018        PMID: 30059639      PMCID: PMC6314398          DOI: 10.1080/21645515.2018.1489193

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  12 in total

1.  Incidence and hospitalization rates of varicella and herpes zoster before varicella vaccine introduction: a baseline assessment of the shifting epidemiology of varicella disease.

Authors:  P Coplan; S Black; C Rojas; H Shinefield; P Ray; E Lewis; H Guess
Journal:  Pediatr Infect Dis J       Date:  2001-07       Impact factor: 2.129

2.  Herpes zoster: Burden of disease in France.

Authors:  S Gonzalez Chiappe; M Sarazin; C Turbelin; A Lasserre; C Pelat; I Bonmarin; O Chosidow; T Blanchon; T Hanslik
Journal:  Vaccine       Date:  2010-10-12       Impact factor: 3.641

3.  Risk factors for postherpetic neuralgia.

Authors:  P W Choo; K Galil; J G Donahue; A M Walker; D Spiegelman; R Platt
Journal:  Arch Intern Med       Date:  1997-06-09

4.  Varicella disease in Beijing in the era of voluntary vaccination, 2007 to 2010.

Authors:  Li Lu; Chengbin Wang; Luodan Suo; Juan Li; Weixiang Liu; Xinghuo Pang; Jane F Seward
Journal:  Pediatr Infect Dis J       Date:  2013-08       Impact factor: 2.129

Review 5.  Clinical practice: Herpes zoster.

Authors:  Jeffrey I Cohen
Journal:  N Engl J Med       Date:  2013-07-18       Impact factor: 91.245

6.  A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction.

Authors:  Barbara P Yawn; Patricia Saddier; Peter C Wollan; Jennifer L St Sauver; Marge J Kurland; Lina S Sy
Journal:  Mayo Clin Proc       Date:  2007-11       Impact factor: 7.616

7.  Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom.

Authors:  A Gauthier; J Breuer; D Carrington; M Martin; V Rémy
Journal:  Epidemiol Infect       Date:  2008-05-09       Impact factor: 2.451

8.  Epidemiology of herpes zoster among adults aged 50 and above in Guangdong, China.

Authors:  Qi Zhu; Huizhen Zheng; Hongying Qu; Huihong Deng; Jikai Zhang; Wenjun Ma; Yongjie Lin; Xin Xie; Quan Qiu; Zhuhang Huang
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

9.  Disease Burden Due to Herpes Zoster among Population Aged ≥50 Years Old in China: A Community Based Retrospective Survey.

Authors:  Yan Li; Zhijie An; Dapeng Yin; Yanmin Liu; Zhuoying Huang; Jianfang Xu; Yujie Ma; Qiufeng Tu; Qi Li; Huaqing Wang
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

10.  Herpes Zoster and Recurrent Herpes Zoster.

Authors:  Kimiyasu Shiraki; Nozomu Toyama; Tohru Daikoku; Misako Yajima
Journal:  Open Forum Infect Dis       Date:  2017-01-28       Impact factor: 3.835

View more
  9 in total

1.  Baculovirus Display of Varicella-Zoster Virus Glycoprotein E Induces Robust Humoral and Cellular Immune Responses in Mice.

Authors:  Wenhui Xue; Tingting Li; Sibo Zhang; Yingbin Wang; Minqing Hong; Lingyan Cui; Hong Wang; Yuyun Zhang; Tingting Chen; Rui Zhu; Zhenqin Chen; Lizhi Zhou; Rongwei Zhang; Tong Cheng; Qingbing Zheng; Jun Zhang; Ying Gu; Ningshao Xia; Shaowei Li
Journal:  Viruses       Date:  2022-08-16       Impact factor: 5.818

2.  The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials.

Authors:  Joon Hyung Kim; John Diaz-Decaro; Ning Jiang; Shinn-Jang Hwang; Eun Ju Choo; Maribel Co; Andrew Hastie; David Shu Cheong Hui; Junya Irimajiri; Jacob Lee; Edward Man-Fuk Leung; Haiwen Tang; Tomomi Tsuru; Philip Watson; Zhenhua Wu; Chong-Jen Yu; Yanfei Yuan; Toufik Zahaf; Anthony L Cunningham; Anne Schuind
Journal:  Hum Vaccin Immunother       Date:  2021-02-19       Impact factor: 3.452

3.  A systematic literature review of herpes zoster incidence worldwide.

Authors:  Désirée van Oorschot; Hilde Vroling; Eveline Bunge; John Diaz-Decaro; Desmond Curran; Barbara Yawn
Journal:  Hum Vaccin Immunother       Date:  2021-03-02       Impact factor: 3.452

4.  The Epidemiology of Herpes Zoster and Postherpetic Neuralgia in China: Results from a Cross-Sectional Study.

Authors:  Fei Yang; Shengyuan Yu; Bifa Fan; Yanqing Liu; Yu Xuan Chen; Ian Kudel; Kristen Concialdi; Marco DiBonaventura; Markay Hopps; Patrick Hlavacek; Joseph C Cappelleri; Alesia Sadosky; Bruce Parsons; Margarita Udall
Journal:  Pain Ther       Date:  2019-06-19

5.  Effect of duloxetine premedication for postherpetic neuralgia within 72 h of herpes zoster reactivation [PROCESS]: a study protocol for a randomized controlled trial.

Authors:  Zheng Chen; Niti Shrestha; Chunmei Zhao; Bifa Fan; Fang Luo
Journal:  Trials       Date:  2020-12-09       Impact factor: 2.279

6.  Teledermatology Service During the COVID-19 Pandemic in China: A Mobile Application-Based Retrospective Study.

Authors:  Zhanglei Mu; Xiaojing Liu; Kun Li; Jianzhong Zhang
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-08-27

7.  Antiviral treatment in outpatients with herps zoster in six major areas of China, 2010-2019.

Authors:  Zhenwei Yu; Yuhua Zhao; Jiayi Jin; Jianping Zhu; Lingyan Yu; Gang Han
Journal:  Front Public Health       Date:  2022-07-29

8.  Risk of herpes zoster after exposure to varicella to explore the exogenous boosting hypothesis: self controlled case series study using UK electronic healthcare data.

Authors:  Harriet Forbes; Ian Douglas; Adam Finn; Judith Breuer; Krishnan Bhaskaran; Liam Smeeth; Simon Packer; Sinéad M Langan; Kathryn E Mansfield; Robin Marlow; Heather Whitaker; Charlotte Warren-Gash
Journal:  BMJ       Date:  2020-01-22

9.  Meta-Regression of Herpes Zoster Incidence Worldwide.

Authors:  Desmond Curran; Andrea Callegaro; Kyle Fahrbach; Binod Neupane; Hilde Vroling; Désirée van Oorschot; Barbara P Yawn
Journal:  Infect Dis Ther       Date:  2021-12-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.